|
|
Annual 1115 Substance Use Disorder (SUD) Waiver Post Award Forum |
Behavioral Health (BH) |
|
|
Coverage of Medications for Treatment of Opioid Use Disorder in Pregnancy |
Retail Pharmacies |
|
|
Maine Point of Purchase System (MEPOPS) Blackout Period |
Retail Pharmacies |
|
|
Roster Billing Hepatitis A Vaccination Codes – CR 116982 |
Hospital & Clinic Services |
|
|
Extended-Release Buprenorphine Clinical Use Criteria |
Hospital & Clinic Services, Primary Care and Care Coordination |
|
|
Training for Licensed Substance Use Disorder (SUD) Providers |
Behavioral Health (BH) |
|
|
MaineCare Notice of Agency Rule-making Proposal, MaineCare Benefits Manual, Ch. III, Section 67, Principles of Reimbursement for Nursing Facilities |
Policy and State Plan Amendments (SPAs), State & Federal Policy |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Services and Supports |
|
|
Rate Determination Initiation Notice for Certified Community Behavioral Health Clinics (CCBHC): MaineCare Benefits Manual (MBM) Section to Be Determined |
Behavioral Health (BH) |
|
|
Attention Section 45 Hospitals, Distinct Psychiatric and Substance Use Disorder (SUD) Units: Rate Determination Update |
Hospital & Clinic Services |
|
|
Extended Release Buprenorphine (XRB) Clinical Use Criteria |
Hospital & Clinic Services, Primary Care and Care Coordination |
|
|
Service Locator Tool – Invitation to Behavioral Health Providers |
Behavioral Health (BH) |
|
|
Attention Providers of Section 107, Psychiatric Residential Treatment Facilities (PRTFs) – Presented Materials and Comment Period |
Behavioral Health (BH) |
|
|
Guidance for Psychiatric Hospitals Seeking Prior Authorization (PA) for Mental Health Intensive Outpatient Services |
Behavioral Health (BH), Hospital & Clinic Services |
|
|
MaineCare Notice of Agency Rule-making Proposal, MaineCare Benefits Manual, Chapter I, Section 4, Telehealth Services |
Policy and State Plan Amendments (SPAs), State & Federal Policy |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Services and Supports |
|
|
Attention Providers of Section 67 Nursing Facilities (NF) and Section 97, Residential Care Facilities (RCFs, PNMI Appendix C): Provider Rate Methodology Workgroup Presented Materials |
Long Term Care Services |
|
|
Johnson & Johnson/Janssen COVID-19 Vaccine No Longer Authorized for Use, CR 118354 |
General, All Services |
|
|
Attention Section 97, Appendix D, Private Non-Medical Institutions (PNMI): Rate Determination Initiation Notice for Therapeutic Foster Care Services |
Behavioral Health (BH) |
|
|
Announcing Acentra Health: A New Era for Client Network Services, Inc (CNSI) and Kepro |
General, All Services |